<?xml version = "1.0" encoding = "utf-8"?>

<rss version="2.0">
	<channel>
		<title> </title> 
		<link>http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events</link> 
		<description> </description> 
		<language>ko</language> 
		<lastBuildDate>Thu, 26 Mar 2026 10:57:13 +0900</lastBuildDate> 
		<webMaster>kingja51@naver.com</webMaster> 

		<item>
			<seq>37512</seq>
			<title><![CDATA[Featured Interview: Managing Director Young Ki Choi on the Future of Basic Science]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37512&amp;upr_ntt_no=37512&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[We are pleased to share a recent featured interview with Young Ki Choi, Managing Director of the Institute for Basic Science (IBS), published by Monthly People.  In this comprehensive dialogue, Managing Director Choi reflects on the pivotal role of basic science as the foundation for national competitiveness. He discusses the strategic vision of IBS in fostering a world-class research environment, supporting young scientists, and strengthening global collaborations.Read the full article here]]></description>
			<pubDate>2026-03-20</pubDate>
			<filename><![CDATA[kvri_Events_0_1773971408.jpg]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>42</hit>
			<filename_str><![CDATA[kvri_Events_0_1773971408.jpg|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
		<item>
			<seq>37511</seq>
			<title><![CDATA[IBS Appoints New Director of the Center for Viral Immunology at the Korea Virus Research Institute]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37511&amp;upr_ntt_no=37511&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[IBS Appoints New Director of the Center for Viral Immunology at the Korea Virus Research InstituteProfessor CHUNG Yeonseok of Seoul National University Named Successor Director   The Institute for Basic Science has appointed Professor CHUNG Yeonseok of the College of Pharmacy at Seoul National University as the new Director of the Center for Viral Immunology at the IBS Korea Virus Research Institute (KVRI). Professor Chung will officially begin his appointment on March 1.   Professor Chung is a]]></description>
			<pubDate>2026-03-01</pubDate>
			<filename><![CDATA[kvri_Events_0_1773971143.jpg]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>29</hit>
			<filename_str><![CDATA[kvri_Events_0_1773971143.jpg|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
		<item>
			<seq>37513</seq>
			<title><![CDATA[Virus &amp; Immunology Experts Gather in Korea]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37513&amp;upr_ntt_no=37513&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[Virus &amp;amp; Immunology Experts Gather in Korea- IBS-KAI-KSV Jointly Host the IBS Conference -- Cutting-edge research in viral immunology to be shared on December 11 to 12 -  The Institute for Basic Science will host the “IBS Conference” featuring leading domestic and international experts in virology and immunology.  Jointly organized by the IBS Korea Virus Research Institute, the Korean Association of Immunologists, and the Korean Society of Virology, the IBS-KAI-KSV Conference on Infection and]]></description>
			<pubDate>2025-12-09</pubDate>
			<filename><![CDATA[kvri_Events_0_1774246641.jpg]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>17</hit>
			<filename_str><![CDATA[kvri_Events_0_1774246641.jpg|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
		<item>
			<seq>37510</seq>
			<title><![CDATA[IBS Launches New Research Group and New Research Center in Virology and Life Sciences]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37510&amp;upr_ntt_no=37510&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[IBS Launches New Research Group and New Research Center in Virology and Life SciencesKAIST Professor PARK Jong-Eun appointed CI of the newly established Systems Virology and Spatial Immunomics Group   IBS has launched a new Chief Investigator(CI) group within the IBS Korea Virus Research Institute (KVRI) effective December 1.  A new Center, the Center for Virome and Applied Platform, has been established within the Korea Virus Research Institute. Within this Center, the first CI group — the Syst]]></description>
			<pubDate>2025-12-01</pubDate>
			<filename><![CDATA[kvri_Events_0_1773970870.png]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>33</hit>
			<filename_str><![CDATA[kvri_Events_0_1773970870.png|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
		<item>
			<seq>37419</seq>
			<title><![CDATA[Designation of the Korea Virus Research Institute as a Specialized Research Institute]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37419&amp;upr_ntt_no=37419&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[The Ministry of Science and ICT has designated the Korea Virus Research Institute, Institute for Basic Science as a National Strategic Technology Specialized Research Institute in the Advanced Bio sector, with a focus on infectious disease vaccines and therapeutics, pursuant to the Act on the Promotion of National Strategic Technologies. The designation is valid for a period of five years, from November 11, 2025, to November 10, 2030.]]></description>
			<pubDate>2025-11-11</pubDate>
			<filename><![CDATA[kvri_Events_0_1764653413.png]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>333</hit>
			<filename_str><![CDATA[kvri_Events_0_1764653413.png|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
		<item>
			<seq>37387</seq>
			<title><![CDATA[2025 IBS-KAI-KSV Conference on Infection and Immunity]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37387&amp;upr_ntt_no=37387&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[The &quot;IBS-KAI-KSV Conference on Infection and Immunity&quot; is scheduled to be held at Daejeon Convention Center 1, Daejeon, Korea, from December 11 to 12, 2025.]]></description>
			<pubDate>2025-10-02</pubDate>
			<filename><![CDATA[kvri_Events_0_1759388296.jpg]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>565</hit>
			<filename_str><![CDATA[kvri_Events_0_1759388296.jpg|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
		<item>
			<seq>37385</seq>
			<title><![CDATA[[Press Release] PB2 and NP of North American H5N1 virus Drive Immune Cell Replication and Systemic infections]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37385&amp;upr_ntt_no=37385&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[A research team led by Director Young Ki Choi at the Korea Virus Research Institute, Institute for Basic Science (IBS), has identified the cause of the fatal pathogenicity of the H5N1 avian influenza virus circulating in North America in mammals. Pathogenicity refers to the property or ability of a pathogen such as a virus or bacterium to infect a host and cause disease. The H5N1 virus was shown not to remain limited to respiratory infection, but to infect immune cells, spread systemically, and]]></description>
			<pubDate>2025-09-29</pubDate>
			<filename><![CDATA[kvri_Events_0_1759148506.png]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>542</hit>
			<filename_str><![CDATA[kvri_Events_0_1759148506.png|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
		<item>
			<seq>37322</seq>
			<title><![CDATA[Recruitment Announcement for IBS-SKKU Specialized Graduate Program]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37322&amp;upr_ntt_no=37322&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[IBS and Sungkyunkwan University jointly invite applications from prospective graduate students for the “IBS–SKKU Specialized Program.”
We look forward to your enthusiastic participation.]]></description>
			<pubDate>2025-09-24</pubDate>
			<filename><![CDATA[kvri_Events_0_1758691940.jpg]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>468</hit>
			<filename_str><![CDATA[kvri_Events_0_1758691940.jpg|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
		<item>
			<seq>37195</seq>
			<title><![CDATA[[Press Release] Therapeutic applications of interface-mimicking peptides for targeting the SARS-CoV-2 NSP12-NSP8 RdRp complex]]></title>
			<author>KVRI</author>
			<link><![CDATA[http://centers.ibs.re.kr/_prog/_board/?code=kvri_Events&amp;mode=V&amp;no=37195&amp;upr_ntt_no=37195&amp;site_dvs_cd=kvri&amp;menu_dvs_cd=0501]]></link>
			<category>kvri_Events</category>
			<description><![CDATA[Amid
growing global concerns over the resurgence of COVID-19 and the emergence of
new variants, a The team designed four structure-based
peptides that selectively bind to NSP12 and block NSP8, thereby inhibiting
viral RNA replication. The peptides showed strong antiviral effects in both
cell experiments and mouse models, offering full protection even with
intranasal administration. The treatment was effective both before and after
infection. Molecular Therapy (IF 12.9) on May 27.AbstractS]]></description>
			<pubDate>2025-05-27</pubDate>
			<filename><![CDATA[kvri_Events_0_1751359802.png]]></filename>
			<filepath><![CDATA[/Upl/_board/kvri_Events/]]></filepath>
			<hit>589</hit>
			<filename_str><![CDATA[kvri_Events_0_1751359802.png|]]></filename_str>
			<moviekey></moviekey>
			<post_dvs_cd></post_dvs_cd>
			
		</item>
		
	</channel>
</rss>